Explore the ACTIV-2 trial's efforts to develop effective COVID-19 treatments in this informative 22-minute lecture by Dr. Kara Chew, Assistant Clinical Professor of Medicine at UCLA. Gain insights into the global and local impact of COVID-19, including case numbers, mortality rates by age, race, and ethnicity, and the disease's progression. Learn about current interventions, symptoms, and treatments. Discover the ACTIV initiative's goals, leadership, and eligibility criteria for the trial. Understand the importance of participant numbers, the types of agents being tested, and the role of monoclonal antibodies in fighting the virus. Delve into the workings of antibody treatments and their potential in combating COVID-19. Conclude with a call to action to spread awareness about this crucial research.